Tuberculosis Vaccine Study Seeks Volunteers

04/02/2019

Saint Louis University’s Center for Vaccine Development is conducting a research study with an investigational Tuberculosis vaccine.

Background

Tuberculosis (TB) is an infectious disease caused by a bacteria (germ) called Mycobacterium tuberculosis (Mtb). People who are sick with TB can spread the germs from one person to another and TB can often cause death. There are medicines that can treat and cure TB disease.  However, strains of Mtb are becoming increasingly resistant to anti-TB medicines.  The only approved and currently licensed vaccine is “BCG”.  It is given to babies in some parts of the world but provides incomplete or only partial protection against TB infection and disease, so there is a great need for a more effective vaccine.

Key Points

• To participate, volunteers must be between the ages of 18 and 55.
• Participation is strictly voluntary.

Payment and Time Commitment

• Participants will be compensated for participating $75 per visit and $10 per phone call.
• There are about nine visits and one phone call over approximately 14 months.

To discuss volunteering, please contact a nurse at 1-866-410-6333 (toll free), by email to vaccine@slu.edu, or by visiting the study.

The Institutional Review Board (IRB) protocol number for the study is #29609 and it was approved on Oct. 5, 2018.

Daniel Hoft, M.D., is the study’s lead investigator.